These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combined modality therapy of non-small cell lung cancers. Juretic A; Sobat H; Samija M Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559 [TBL] [Abstract][Full Text] [Related]
23. Treatment of advanced non-small cell lung cancer in the elderly. Sequist LV; Fidias P Semin Respir Crit Care Med; 2005 Jun; 26(3):289-97. PubMed ID: 16052430 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [TBL] [Abstract][Full Text] [Related]
25. Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece. Bakogeorgos M; Mountzios G; Bournakis E; Economopoulou P; Kotsantis G; Fytrakis N; Kouvatseas G; Dimopoulos MA; Kentepozidis N J Geriatr Oncol; 2015 Mar; 6(2):111-8. PubMed ID: 25482021 [TBL] [Abstract][Full Text] [Related]
26. Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). Firat S; Pleister A; Byhardt RW; Gore E Am J Clin Oncol; 2006 Jun; 29(3):252-7. PubMed ID: 16755178 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy in advanced non-small cell lung cancer. Evans T Semin Respir Crit Care Med; 2005 Jun; 26(3):304-13. PubMed ID: 16052432 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614 [TBL] [Abstract][Full Text] [Related]
29. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy. Bunn PA Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594 [TBL] [Abstract][Full Text] [Related]
30. [Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC)]. Clement D; Miron L; Marinca M Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):856-63. PubMed ID: 18389770 [TBL] [Abstract][Full Text] [Related]
31. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer. Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225 [TBL] [Abstract][Full Text] [Related]
33. Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer. Yoshimura N; Kudoh S; Kimura T; Mitsuoka S; Kyoh S; Tochino Y; Asai K; Kodama T; Ichimaru Y; Yana T; Hirata K J Thorac Oncol; 2009 Mar; 4(3):371-5. PubMed ID: 19155998 [TBL] [Abstract][Full Text] [Related]
34. Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients. Rossi A; Maione P; Gridelli C Expert Opin Drug Saf; 2005 Nov; 4(6):1051-67. PubMed ID: 16255664 [TBL] [Abstract][Full Text] [Related]
35. The Treatment of Advanced Lung Cancer in the Elderly: The Role of a Comprehensive Geriatric Assessment and Doublet Chemotherapy. Presley C; Lilenbaum R Cancer J; 2015; 21(5):392-7. PubMed ID: 26389764 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of advanced non-small-cell lung cancer in elderly patients]. Miyauchi E; Inoue A Gan To Kagaku Ryoho; 2015 Jan; 42(1):6-11. PubMed ID: 25596674 [TBL] [Abstract][Full Text] [Related]
37. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients. Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer. Xue D; Han S; Jiang S; Sun H; Chen Y; Li Y; Wang W; Feng Y; Wang K; Li P Med Oncol; 2015 Apr; 32(4):114. PubMed ID: 25772512 [TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer. Gridelli C; Maione P; Comunale D; Rossi A Cancer Control; 2007 Jan; 14(1):57-62. PubMed ID: 17242671 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA; J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]